Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression-Reference-Cited by-同舟云学术

Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression

Published:2014-07 Issue:7 Volume:21 Page:841-854
ISSN:1074-5521
Container-title:Chemistry & Biology
language:en
Short-container-title:Chemistry & Biology

Author:

Gacias Mar,Gerona-Navarro Guillermo,Plotnikov Alexander N.,Zhang Guangtao,Zeng Lei,Kaur Jasbir,Moy Gregory,Rusinova Elena,Rodriguez Yoel,Matikainen Bridget,Vincek Adam,Joshua Jennifer,Casaccia Patrizia,Zhou Ming-Ming

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,General Medicine,Biochemistry

Reference43 articles.

1. Relationship between cell cycle molecules and onset of oligodendrocyte differentiation;Casaccia-Bonnefil;J. Neurosci. Res.,2003

2. Brd4 engagement from chromatin targeting to transcriptional regulation: selective contact with acetylated histone H3 and H4;Chiang;F1000 Biol. Rep.,2009

3. Dual kinase-bromodomain inhibitors for rationally designed polypharmacology;Ciceri;Nat. Chem. Biol.,2014

4. Intramolecular dipolar cycloaddition reactions to give substituted indoles—a formal synthesis of deethylibophyllidine;Coldham;Eur. J. Org. Chem.,2007

5. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia;Dawson;Nature,2011

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of a brain-permeable bromodomain and extra terminal domain (BET) inhibitor with selectivity for BD1 for the treatment of multiple sclerosis;European Journal of Medicinal Chemistry;2024-02

2. DW71177: A novel [1,2,4]triazolo[4,3-a]quinoxaline-based potent and BD1-Selective BET inhibitor for the treatment of acute myeloid leukemia;European Journal of Medicinal Chemistry;2024-02

3. Structure-Guided Design and Synthesis of Pyridinone-Based Selective Bromodomain and Extra-Terminal Domain (BET)-First Bromodomain (BD1) Inhibitors;Journal of Medicinal Chemistry;2024-01-31

4. Discovery of Novel Phenoxyaryl Pyridones as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with High Selectivity for the Second Bromodomain (BD2) to Potentially Treat Acute Myeloid Leukemia;Journal of Medicinal Chemistry;2024-01-04

5. Visible-light-promoted cyclization of 3-indolylallylamides enabling synthesis of tetrahydrocarbolinones;Tetrahedron;2024-01